Skip to main content
Bodal Chemicals Ltd logo

Bodal Chemicals Ltd — Investor Relations & Filings

Ticker · BODALCHEM ISIN · INE338D01028 LEI · 33580055P81L7PGHUJ40 BSE.NS Manufacturing
Filings indexed 1,548 across all filing types
Latest filing 2025-05-24 Regulatory Filings
Country IN India
Listing BSE.NS BODALCHEM

About Bodal Chemicals Ltd

https://www.bodal.com/

Bodal Chemicals Ltd is a vertically integrated manufacturer specializing in dyestuffs, dye intermediates, and basic chemicals. The product portfolio includes a wide range of reactive, acid, and direct dyes, alongside key intermediates such as H-Acid and Vinyl Sulphone. The chemical division produces sulfuric acid, chloro sulfonic acid, and liquid sulfur trioxide. By maintaining a high degree of backward integration, the company ensures cost-efficiency and consistent quality across its manufacturing chain. It serves diverse global markets, primarily catering to the textile, leather, paper, and plastic sectors. The organization focuses on large-scale production capabilities and technical expertise to provide chemical solutions for industrial applications worldwide.

Recent filings

Filing Released Lang Actions
Bodal Chemicals limited herewith Intimate receipt of request for the reclassification from Promoter / Promoters group to the Public category in accordance with the Regulation 31a of SEBI ....
Regulatory Filings
2025-05-24 English
General Updates
Major Shareholding Notification Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the receipt of requests from members of the promoter/promoter group for reclassification to the public category. It references Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs such reclassification. The document includes detailed letters from the promoters explaining their reasons for reclassification and confirming compliance with regulatory conditions. There are no financial statements, earnings data, or management discussion of financial results. The content is regulatory and compliance-related, specifically about changes in shareholding classification and related approvals. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership or classification levels. The document length and detail confirm it is not a brief announcement but a substantive notification. Therefore, the appropriate classification is MRQ with high confidence.
2025-05-24 English
Bodal Chemicals Limited herewith inform Exchange about Intimation for Q4 & FY25 Earnings Call
Regulatory Filings
2025-05-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 85% confidence The document is an announcement of an upcoming earnings call for Q4 and FY25, including details such as date, time, dial-in numbers, and participants. It does not contain actual financial results or substantive financial data but rather invites investors and stakeholders to a conference call where such information will be discussed. The document length is 4083 characters, which is relatively short and consistent with an announcement rather than a full report or transcript. Therefore, this document is best classified as a Call Transcript (CT) announcement, but since it is only the invitation and not the transcript itself, it fits the category of a Call Transcript (CT) type document as per the definitions provided, which includes full text transcripts of company conference calls. However, since this is only an invitation and not the transcript, the closest and most appropriate classification is Call Transcript (CT) with moderate confidence, as it is related to the earnings call but not the transcript itself. Given the options, CT is the best fit.
2025-05-22 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-05-21 English
Bodal Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2025 ,inter alia, to consider and approve standalone and consolidated ....
Regulatory Filings
2025-05-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.